GRI Bio's market cap is currently $5.06M. The company's EPS TTM is $-1.39; its P/E ratio is ―; GRI Bio is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
